Beruflich Dokumente
Kultur Dokumente
M
• Riwayat Pendidikan
• S1 Fakultas Kedokteran Universitas Hasanuddin, Makassar tahun 2003-2006
• Profesi Kedokteran Universitas Hasanuddin, Makassar tahun 2007-2009
• Kursus Tagalog English Language di Emilio Aguinaldo College, Philippines, July
2013
• Residency Training Program of Ophthalmology in Rizal Medical Center,
Philippines, tahun 2013-2017
• Program adaptasi Ilmu Kesehatan Mata Fakultas Kedokteran Universitas
Hasanuddin, Makassar, tahun 2019
• Karya Ilmiah
• Association Between Hyperglycemia and Retinopathy of Prematurity (ROP)
among Premature Infants Admitted in Neonatal Intensive Care Unit (NICU) at
the Rizal Medical Center (RMC). Free paper Presenter di 3rd Asean
Ophthalmology Society Congress 2017, Jakarta, 20 July 2017.
• True ocular emergency requiring immediate
assessment and initiation of treatment.
• Produce extensive damage to the ocular surface
epithelium, cornea, anterior segment and limbal stem
cells resulting in permanent unilateral or bilateral
visual impairment.
• The evolution of cicatrisation in severe chemical injuries
especially alkali, takes an unfavourable course.
• The offending chemical may be in the form of a solid,
liquid, powder, mist, or vapor
• The severity of a chemical injury depends on
• pH
• Volume and duration of contact
• Concentration
• Toxicity of the chemical
• Temperature
• Impact force
• The specific reactivity with tissue (pK)
Rafii AB, et al. Current and Upcoming Therapies for Ocular Surface Chemical Injuries. Ocul Surf. 2017 January ; 15(1): 48–64.
doi:10.1016/j.jtos.2016.09.002
• Chemical injuries to the eye represent between 11.5%-22.1%
of ocular traumas.
• 2/3rd occur in young men and children age 1-2 years
• The vast majority of the injuries occur in the workplace as a
result of industrial accidents.
• A minority of injuries occur in the home or secondary to assault.
• Alkali materials are found more commonly in building materials
and cleaning agents and occur more frequently than acid
injuries.
Wagoner, M.D., Chemical injuries of the eye: current concepts in pathophysiology and
therapy. Survey of ophthalmology, 1997. 41(4): p. 275-313
ALKALIES ACID
IRRITANTS
ACID
Substance Chemical Composition Found in
Sulfuric acid H2SO4 Car batteries
Sulfurous acid H2SO2 Bleach and refrigerant
Hydrofluoric acid HF Glass polishing and mineral refining
Acetic Acid CH2COOH Vinegar, glacial acetic acid
Hydrochloric acid HCl Swimming pools
Alkali
Substance Chemical Composition Found in
Ammonia NH2 Cleaning agents, fertilizers,
refrigerants
Potassium Hydroxide KOH Caustic potash
Lye NaOH Drain cleaners, airbags
Magnesium Hydroxide Mg (OH)2 Firework sparklers, flares
Lime Ca(OH)2 Plaster, mortar, cement, white wash
No. Active Ingredients Found in pH
1. Accelerated hydrogen peroxide (0.5%) Vanish 4.5-7
pH 4.5-7
2. Benzalkonium chloride/ quaternary ammonium/ Bebek Kamar Mandi, 2-11
alkyl dimethyl benzyl ammonium chloride Bratacare, Mr. Muscle, (cationic
(0.05%) Disinfectane concentrate surfactant)
Daftar Sementara Bahan Aktif dan Produk Rumah Tangga untuk Disinfeksi Virus Corona Penyebab Covid-19. http://lipi.go.id/berita/Daftar-
Sementara-Bahan-Aktif-dan-Produk-Rumah-Tangga-untuk-Disinfeksi-Virus-Corona-Penyebab-COVID-19/21979
Agent Industry Use Ocular Toxicity
Surfactants, detergents Cleaning Pain; lacrimation; photophobia; anterior
(anionic) segment damage (cationic)
Benzalkonium; chloride
Hydrocarbons, gasoline, Fuel Mild conjunctivitis; usually no corneal
kerosene involvement
Aromatic (hydrocarbons); Solvents used in Mild corneal damage with rapid healing;
benzene, toluene, xylene laboratories damage nerve endings; pain
Hydrogen peroxide Cleaning; Ocular irritation (household strength)
oxidizing agent
Trichloroethane; Dry cleaning Ocular irritation
trichloroethylene
Alcohols antiseptic Mild irritation (dilute), epithelial damage,
toxic keratopathy
Formaldehyde Preservation of Immediate pain and minimal structural
specimen damage; over the next 12 hours, all layers of
cornea and areas of anterior chamber
undergo degeneration
Raise the pH of ocular tissues
Cellular disruption
Figure 3.
Decrease the pH of ocular tissue
SURGICAL THERAPY
1. Removing the offending agent
2. Promoting ocular surface
healing
3. Controlling inflammation
4. Preventing infection
5. Controlling IOP
Antibiotics Cycloplegic Artificial Tears
Platelet Rich
Steroid eye drop Ascorbic Acid Plasma eye drops
To prevent infection
GRADE I : a topical antibiotic
ointment (e.g. erythromycin
Antibiotics ointment)
GRADE II ABOVE : stronger
topical antibiotic eye drop
(e.g. fluoroquinolone)
Recommended for patients with
significant anterior chamber
reaction
Cycloplegic Reduce ciliary spasm and pain
Prevent posterior synechiae
Atropine 0.5% or
Cyclopentolate 1%
Preferably preservative free q2h
Reduce the risk of recurrent erosions
Facilitating corneal epithelial migration
and minimizing conjunctival scarring and
Artificial Tears
symblepharon formation
Reduce inflammatory cell infiltration and
stabilize neutrophilic cytoplasmic and
lysosomal membranes.
In MILD INJURIES : topical prednisolone
acetate 1% 4 dd 1 gtt
In SEVERE INJURIES : topical prednisolone
Steroid eye drop acetate 1% can be used every hour
Given in the initial phase
After 1 week, the steroids should be
tapered because the balance of collagen
synthesis vs collagen breakdown may tip
unfavorably toward collagen breakdown
Promote synthesis of mature collagen by
corneal fibroblasts
severe alkali burns in rabbit eyes were
associated with reduced ascorbic acid
levels in the aqueous humor Ascorbic Acid
This reduction correlated with corneal
stromal ulceration and perforation.
In Adult the dose of oral Vitamin C up to
2 grams/ day
Contains growth factor and fibronectin
benefit in promoting reepithelialization
Can lead to faster epithelialization
The difference between autologous PRP
and autologous serum is the platelets
preserved in the autologous PRP.
Platelets are great sources of growth Platelet Rich
factors such as platelet-derived growth Plasma eye drops
factors (PDGFs) aa, bb, and ab,
transforming growth factors (TGFs) β1 and
β2, vascular endothelial growth factor, and
epithelial growth factor.
Keep the bottles in a dark, cool place
under refrigeration at 4°C and prepared
every week
• Doxycycline- acts independently of its antimicrobial properties to reduce the
effects of matrix metalloproteinases (MMPs), which can
• Degrade type I collagen. (caution in children and females of childbearing age)
• Suppression of alpha 1 antitrypsin degradation and scavenging reactive oxygen
species
• Reducing ocular surface inflammation
• Dosis Doxycycline 100 mg BID
• Collagenase inhibitors: Collagenase inhibitors promote wound healing by
inhibiting collagenolytic activity and thus preventing stromal ulceration.
Several collagenase inhibitors including cysteine, acetylcysteine, and citrate
10% have been reported to be efficacious. Only 10-20% acetylcysteine
(mucomist) is available commercially. It is an unstable solution and has to be
refrigerated and used within 1 week of its preparation.
• given 1 week after injury
• Increase IOP : give oral carbonic anhydrase inhibitors (Acetazolamide tab
250 mg 2-4 x 1/ day)
• Bandage soft contact lens
• Hydrophilic high oxygen permeability lenses should be
preferred.
• To promote epithelial migration, helps in the basement
membrane regeneration and enhances epithelial stromal
adhesion
• To protect the migrating epithelium from the ‘windshield-
wiper’ effect of the eyelids
Hemmati HD, Colby KA. Treating Acute Chemical Injuries of the Cornea.2012. https://www.aao.org/eyenet/article/treating-acute-
chemical-injuries-of-cornea
• Topical antibiotic drop like fluoroquinolone four times daily
• Prednisolone acetate 1% hourly while awake for the first 7-10
days. Consider tapering the steroid if the epithelium has not
healed by day 10-14
• Long acting cycloplegic like atropine
• Preservative free artificial tears as needed
• Oral Vitamin C, 2 grams in four times a day
• Doxycycline, 100 mg twice a day (avoid in children)
• Debridement of necrotic epithelium
• Medical Therapy
• Topical antibiotics, cycloplegics, ascorbate, tetracycline should be continued.
• Topical steroids should be discontinued or tappered off unless the patient is
observed daily.
• Ocular hypotensives should be continued if the intraocular pressure remains high.
• A glued-on contact lens may be considered in severe burns with complete
denudation of the cornea and no corneal melting.
• N-acetylcysteine (Mucomyst) 10% solution every hour
• Autologous or homologous serum can be applied dropwise
• Lysis of adhesions to prevent symblepharon.
• Bandage Contact Lens
• Surgical Therapy
• Tarsorraphy
• Consider Amniotic Membrane Transplant in grade III-IV
Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular Chemical Injuries and Their management. Oman J Ophthalmol. 2013 May-Aug; 6(2): 83–
86.
Ralph RA. Chemical Injuries of the Eye. Duane’s Ophthalmology. 2006. New York: Lippincott Williams & Wilkins
• Medical Therapy
• Surgical Therapy
•Amniotic membrane transplantation
•Conjunctival/tenons advancement
•Tissue adhesives
•Therapeutic penetrating keratoplasty
Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular Chemical Injuries and Their management.
Oman J Ophthalmol. 2013 May-Aug; 6(2): 83–86.
Ralph RA. Chemical Injuries of the Eye. Duane’s Ophthalmology. 2006. New York: Lippincott Williams
& Wilkins
• The tear film should be augmented when
necessary with preservative-free artificial tears. Heavily vascularized cornea with
symblepharon several years after
• Lysis of symblephara and reconstruction of the severe chemical burn.
fornices, possibly with mucosal grafts, may be
performed. Silicone rubber sheets and an acrylic
conformer are useful.
• Correction of cicatricial entropion and trichiasis is
necessary if keratoplasty is anticipated.
Opacification of keratoplasty in
• Penetrating keratoplasty heavily vascularized cornea
Conjunctival inflammation
Corneal abrasions
Corneal haze and edema
Iritis
Acute rise in IOP
Corneal melting and
perforations
EYELID
Trichiasis
Madarosis
Ankyloblepharon
CONJUNCTIVA
Scarring (destruction of goblet cells &
accessory lacrimal glands
Severe dryness
Symblepharon
Pseudopterygium
CORNEA
Corneal ulceration
Recurrent corneal erosions
Corneal opcification
Vascularization thinning & perforation
SECONDARY GLAUCOMA
ATROPHIC BULBI
• Chemical eye injury is a true ocular emergency
• Requiring immediate assessment and initiation of treatment.
• The goals in treatment of chemcal eye injury are
1. Removing the offending agent
2. Promoting ocular surface healing
3. Controlling inflammation
4. Preventing infection
5. Controlling IOP
1. Ilyas, Sidarta. Kedaruratan Dalam Ilmu Penyakit Mata. 2009. Jakarta: Fakultas Kedoktera
Universitas Indonesia
2. American Academy of Ophthalmology. External Disease and Cornea. 2016-2017.
3. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmology
2001;85:1379-83.
4. Lusk PG. Chemical Eye Injuries in the Workplace : Prevention and Management. AAOHN Journal
1999;47(2): 80-7.
5. Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular Chemical Injuries and Their management.
Oman J Ophthalmol. 2013 May-Aug; 6(2): 83–86.
6. Gupta N, Kalaivani M, Tandon R. Comaprison of Prognostic Value of Roper Hall and Dua
Classification Systems in Acute Ocular Burns. Br J Ophthalmol 2011 Feb;95(2):194-8
7. Trief D, Chodosh J, Colby K, Chang A. Chemical (Alkali and Acid) Injury of the conjunctiva and
Cornea. 2020.
https://eyewiki.aao.org/Chemical_(Alkali_and_Acid)_Injury_of_the_Conjunctiva_and_Cornea#cite
_note-Wagoner-2
8. Wu TE, Chen CJ, Hu CC, Cheng CK. Easy to prepare autologous platelet-rich plasma in the
treatment of refractory corneal ulcers. Taiwan J Ophthalmol. 2015 Jul-Sep; 5(3): 132–135.
9. Rafii AB, et al. Current and Upcoming Therapies for Ocular Surface Chemical Injuries. Ocul Surf.
2017 January ; 15(1): 48–64. doi:10.1016/j.jtos.2016.09.002
10. Mishra BP, Mahapatra A, Sahu SK, Naik C, Dany SS. Incidence and Management if Chemical
Injuries of Eyes. 2019. Journal of Medical Science and Clinical Research 07(06); 807-12.
11. Arora R, Mehta D, Jain V. Aminiotic membrane transplantation in acute chemical burns. 2005. Eye
19: 273-278